CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 75-95% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Novartis publishes Q3 impact and sustainability update

By Public Technologies
  • Novartis committed at least USD 250 million to Global Health research and development for 2026-2030 in its impact and sustainability update.
  • The FDA granted Priority Review to antimalarial KLU156, shortening its evaluation period from 10 months to six months.
  • Phase II studies of oral leishmaniasis treatment LXE408 in India and Ethiopia concluded; results are scheduled for presentation November 18, 2026.
  • The group retained first place in the 2026 Access to Medicine Index, ranking first across all three technical areas.
  • Water consumption in its own operations fell 59% in 2025 versus 2016; site-specific targets now cover prioritized operations in water-stressed basins.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novartis AG published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.